Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma.

  • Read more about Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma.

KIR-Favorable TCR-αβ/CD19-Depleted Haploidentical HCT in Children with ALL/AML/MDS: Primary Analysis of PTCTC ONC1401.

  • Read more about KIR-Favorable TCR-αβ/CD19-Depleted Haploidentical HCT in Children with ALL/AML/MDS: Primary Analysis of PTCTC ONC1401.

Metabolomic Identification of Alpha-Ketoglutaric Acid Elevation in Pediatric Chronic Graft-versus-Host Disease.

  • Read more about Metabolomic Identification of Alpha-Ketoglutaric Acid Elevation in Pediatric Chronic Graft-versus-Host Disease.

Out of Specification Tisagenlecleucel Does Not Compromise Safety or Efficacy in Pediatric Acute Lymphoblastic Leukemia.

  • Read more about Out of Specification Tisagenlecleucel Does Not Compromise Safety or Efficacy in Pediatric Acute Lymphoblastic Leukemia.

T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis.

  • Read more about T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis.

Double trouble for Langerhans cell histiocytosis.

  • Read more about Double trouble for Langerhans cell histiocytosis.

The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury.

  • Read more about The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury.

A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.

  • Read more about A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.

Tumor Thrombus- a Single Center Experience with Tumor Thrombus and Role of Anticoagulation

  • Read more about Tumor Thrombus- a Single Center Experience with Tumor Thrombus and Role of Anticoagulation

Response of Patients with Transfusion-Dependent ß-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for ß-Thalassemia) Gene Therapy Based on HBB Genotype and Disease Genetic Modifiers.

  • Read more about Response of Patients with Transfusion-Dependent ß-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for ß-Thalassemia) Gene Therapy Based on HBB Genotype and Disease Genetic Modifiers.

Pagination

  • Previous page ‹‹
  • Page 8
  • Next page ››
Subscribe to Blood

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List